Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Journal of Patient-Reported Outcomes|March 29, 2022
Health-related quality of life in patients with COVID-19; international development of a patient-reported outcome measureCecilie Delphin Amdal, Katherine Taylor, Dagmara Kuliś, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|October 23, 2022
A multicenter international prospective study of the validity and reliability of a COVID-19-specific health-related quality of life questionnaireCecilie Delphin Amdal, Ragnhild Sørum Falk, Susanne Singer, et al.
The Lancet. Oncology|June 3, 2023
Setting International Standards in Analyzing Patient-Reported Outcomes and Quality of Life Endpoints in Cancer Clinical Trials-Innovative Medicines Initiative (SISAQOL-IMI): stakeholder views, objectives, and proceduresMadeline Pe, Ahu Alanya, Ragnhild Sorum Falk, et al.
Head & Neck|August 1, 2025
Late Toxicity and Long-Term Quality of Life in Survivors of Cancer of the Major Salivary Glands More Than 5 Years After Diagnosis: A Multi-National StudySusanne Singer, Cecilie Delphin Amdal, Kristin Bjordal, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|July 17, 2021
Methodological approach for determining the Minimal Important Difference and Minimal Important Change scores for the European Organisation for Research and Treatment of Cancer Head and Neck Cancer Module (EORTC QLQ-HN43) exemplified by the Swallowing scaleSusanne Singer, Eva Hammerlid, Iwona M Tomaszewska, et al.
Head & Neck|January 13, 2019
International validation of the revised European Organisation for Research and Treatment of Cancer Head and Neck Cancer Module, the EORTC QLQ-HN43: Phase IVSusanne Singer, Cecilie Delphin Amdal, Eva Hammerlid, et al.
Critical Care (London, England)|January 10, 2023
Efficacy and safety of baricitinib in hospitalized adults with severe or critical COVID-19 (Bari-SolidAct): a randomised, double-blind, placebo-controlled phase 3 trialMarius Trøseid, José R Arribas, Lambert Assoumou, et al.
Pageof 3